논문상세정보
-
- 저자 Mungmunpuntipantip Rujittika Wiwanitkit Viroj
- 제어번호 108287321
- 학술지명 Infection and Chemotherapy
- 권호사항 Vol. 54 No. 3 [ 2022 ]
- 발행처 대한감염학회
- 자료유형 학술저널
- 수록면 547-548 ( 2쪽)
- 언어 English
- 출판년도 2022
- 등재정보 KCI등재
- 판매처
유사주제 논문( 0)
Regdanvimab Treatment of COVID-19
' Regdanvimab Treatment of COVID-19' 의 참고문헌
-
Real World Experience with Regdanvimab Treatment of Mild-to-Moderate Coronavirus Disease-19 in a COVID-19 Designated Hospital of KoreaHong Sun In [2022]
-
COVID-19 : angiotensin-converting enzyme 2(ACE2)expression and tissue susceptibility to SARS-CoV-2 infectionBeyerstedt S [2021]
-
Angiotensin-converting enzymes(ACE, ACE2)gene variants and COVID-19outcomeGómez J [2020]